Understanding Urothelial Bladder Cancer

Urothelial bladder cancer (UBC) is the most common form of bladder cancer and ranks as the sixth most frequent cancer diagnosis in the United States. Each year, approximately 85,000 individuals are diagnosed with the condition. Fortunately, advancements in medical treatment, particularly immunotherapy, have provided new avenues for patient care.

How Immunotherapy Works

Immunotherapy is a specialized treatment that empowers the body’s own immune system to identify and destroy cancer cells. The immune system consists of a complex network of organs, cells, and proteins designed to protect the body from foreign substances called antigens. When the immune system detects these antigens on bacteria, viruses, or tumors, it triggers an immune response to eliminate the threat.

Key Immune System Components

  • Macrophages: These cells consume and analyze harmful substances in large quantities, allowing other immune cells to identify and destroy them.
  • Regulatory T Cells: These cells monitor and balance the immune system to prevent it from overreacting or attacking the body's healthy tissues.

Types of Immunotherapy for UBC

Immunotherapy generally functions in two primary ways: by enhancing the body's natural ability to fight cancer or by using lab-made components to target specific threats. Current treatments include:

Immune Checkpoint Inhibitors

Cancer cells often exploit immune checkpoints to "put the brakes" on the immune system, allowing them to grow unchecked. Checkpoint inhibitors release these brakes, enabling the immune system to remain active. Specifically, these inhibitors target PD-L1 or PD-1 proteins to shrink tumors or slow their progression.

Intravesical Therapy

These liquid-based therapies are inserted directly into the bladder. They are typically reserved for earlier, less invasive stages of bladder cancer and work by triggering a localized immune response to attack cancer cells.

Antibody-Drug Conjugates

These treatments utilize manmade antibodies linked to chemotherapy drugs. The antibodies act as a delivery system, directing the chemotherapy medication specifically to the cancer cells for more efficient treatment.

Can Immunotherapy Be Combined with Other Treatments?

Yes, immunotherapy can be used in combination with other medications depending on the tumor type and the stage of the cancer. It is also frequently utilized alongside traditional treatment methods, including surgery, radiation, and chemotherapy, to achieve more effective clinical outcomes.